Admission levels of soluble CD137 are increased in patients with acute pancreatitis and are associated with subsequent complications

Experimental and Molecular Pathology

Volumn 92, Issue 1, 2012, Pages 1-6

  Shao, Zhe ^a   Schäffler, Andreas ^a   Hamer, Okka ^b   Dickopf, Judith ^b   Goetz, Andrea ^b   Landfried, Karin ^b   Voelk, Markus ^b   Kopp, Andrea ^b   Herfarth, Hans ^c   Karrasch, Thomas ^b   Brünnler, Tanja ^b   Koh, Liang Kai ^a   Buechler, Christa ^b   Schwarz, Herbert ^a,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Acute pancreatitis; Peripancreatic necrosis; Soluble CD137

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CD137 ANTIGEN; CREATININE; LACTATE DEHYDROGENASE; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOLIC PANCREATITIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GALLSTONE; HOSPITAL ADMISSION; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOGENESIS; PROBABILITY; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SURVIVAL RATE; T LYMPHOCYTE; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD137; APACHE; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PANCREAS; PANCREATITIS; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 80155191158     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.09.012     Document Type: Article

References (36)

1. Ammori B.J., et al. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J. Gastrointest. Surg. 1999, 3:252-262.
2. Beger H.G., Rau B.M. Severe acute pancreatitis: clinical course and management. World J. Gastroenterol. 2007, 13:5043-5051.
3. Bossuyt P.M., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. The Standards for Reporting of Diagnostic Accuracy Group. Croat. Med. J. 2003, 44:639-650.
4. Charbonney E., Nathens A.B. Severe acute pancreatitis: a review. Surg. Infect. (Larchmt) 2008, 9:573-578.
5. Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 2009, 9:271-285.
6. Curley P.J., et al. Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: relationship to endotoxin, interleukin 6 and disease severity. Br. J. Surg. 1993, 80:1312-1315.
7. Dabrowski A., et al. Monocyte subsets and natural killer cells in acute pancreatitis. Pancreatology 2008, 8:126-134.
8. Demols A., et al. CD4(+ )T cells play an important role in acute experimental pancreatitis in mice. Gastroenterology 2000, 118:582-590.
9. Dongming L., et al. Enhanced levels of soluble and membrane-bound CD137 levels in patients with acute coronary syndromes. Clin. Chim. Acta 2010, 411:406-410.
10. Drenkard D., et al. CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity. FASEB J. 2007, 21:456-463.
11. Dugernier T.L., et al. Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. Am. J. Respir. Crit. Care Med. 2003, 168:148-157.
12. Furtner M., et al. Levels of soluble CD137 are enhanced in sera of leukemia and lymphoma patients and are strongly associated with chronic lymphocytic leukemia. Leukemia 2005, 19:883-885.
13. Harper S.J., Cheslyn-Curtis S. Acute pancreatitis. Ann. Clin. Biochem. 2011, 48:23-37.
14. Hasibeder W.R., et al. Critical care of the patient with acute pancreatitis. Anaesth. Intensive Care 2009, 37:190-206.
15. Holland J., et al. Intraoperative splanchnic hypoperfusion, increased intestinal permeability, down-regulation of monocyte class II major histocompatibility complex expression, exaggerated acute phase response, and sepsis. Am. J. Surg. 2005, 190:393-400.
16. Janssen O., et al. Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell Tissue Res. 2000, 301:85-99.
17. Jung H.W., et al. Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis. Exp. Mol. Med. 2004, 36:13-22.
18. Juvonen P.O., et al. Splanchnic tissue perfusion in acute experimental pancreatitis. Scand. J. Gastroenterol. 1999, 34:308-314.
19. Kim C.S., et al. The immune signaling molecule 4-1BB stimulation reduces adiposity, insulin resistance, and hepatosteatosis in obese mice. Endocrinology 2010, 151:4725-4735.
20. Lipsett P.A. Serum cytokines, proteins, and receptors in acute pancreatitis: mediators, markers, or more of the same?. Crit. Care Med. 2001, 29:1642-1644.
21. Makela A., et al. Serum phospholipase A2, amylase, lipase, and urinary amylase activities in relation to the severity of acute pancreatitis. Eur. J. Surg. 1997, 163:915-922.
22. Mayer J.M., et al. Single doses of FK506 and OKT3 reduce severity in early experimental acute pancreatitis. Eur. J. Surg. 2000, 166:734-741.
23. Michel J., Schwarz H. Expression of soluble CD137 correlates with activation-induced cell death of lymphocytes. Cytokine 2000, 12:742-746.
24. Michel J., et al. A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis. Eur. J. Immunol. 1998, 28:290-295.
25. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J. Clin. Invest. 2003, 111:1805-1812.
26. Pietruczuk M., et al. Alteration of peripheral blood lymphocyte subsets in acute pancreatitis. World J. Gastroenterol. 2006, 12:5344-5351.
27. Schaffler A., et al. Admission resistin levels predict peripancreatic necrosis and clinical severity in acute pancreatitis. Am. J. Gastroenterol. 2010, 105:2474-2484.
28. Schaffler A., et al. Admission visfatin levels predict pancreatic and peripancreatic necrosis in acute pancreatitis and correlate with clinical severity. Am. J. Gastroenterol. 2011, 106:957-967.
29. Scholmerich J. Interleukins in acute pancreatitis. Scand. J. Gastroenterol. Suppl. 1996, 219:37-42.
30. Sharief M.K. Heightened intrathecal release of soluble CD137 in patients with multiple sclerosis. Eur. J. Neurol. 2002, 9:49-54.
31. Takeyama Y., et al. Peripheral lymphocyte reduction in severe acute pancreatitis is caused by apoptotic cell death. J. Gastrointest. Surg. 2000, 4:379-387.
32. Thum E., et al. CD137, implications in immunity and potential for therapy. Front. Biosci. 2009, 14:4173-4188.
33. Tsuji N., et al. Specific interaction of pancreatic elastase and leucocytes to produce oxygen radicals and its implication in pancreatitis. Gut 1994, 35:1659-1664.
34. Uehara S., et al. Immune function in patients with acute pancreatitis. J. Gastroenterol. Hepatol. 2003, 18:363-370.
35. Vonlaufen A., et al. The role of inflammatory and parenchymal cells in acute pancreatitis. J. Pathol. 2007, 213:239-248.
36. Wang C., et al. Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol. Rev. 2009, 229:192-215.